Prior to speaking at the upcoming MedCity INVEST conference in Chicago, panelists Jessica Zeaske and Dr. Akhil Saklecha weighed in on what differentiates provider-led and payer-led funds from traditional VCs.
Venture funds can help providers maintain a pulse on upcoming market disruptions and capitalize on a first-mover advantage, while ideally yielding a positive financial return.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.